Form 4 Filing by Cynthia M. Butitta

Cynthia M. Butitta, a director at Autolus Therapeutics plc, reported the acquisition of 31,667 Restricted Share Units (RSUs) and 47,500 Share Options on June 29, 2026. The RSUs, each representing a contingent right to one American Depositary Share (ADS), vest on June 29, 2027. The share options, with an exercise price of $1.61, vest in twelve equal monthly installments starting July 29, 2026. These transactions were reported on a Form 4 filing dated July 1, 2026. Butitta holds these as direct owner. The filing indicates that each ADS is convertible into one Ordinary Share. This is a significant transaction for an insider, indicating potential future equity gains and commitment to the company.